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Spatial analysis of Cdc42 activity reveals a role 
for plasma membrane–associated Cdc42 in 
centrosome regulation
ABSTRACT The ability of the small GTPase Cdc42 to regulate diverse cellular processes de­
pends on tight spatial control of its activity. Cdc42 function is best understood at the plasma 
membrane (PM), where it regulates cytoskeletal organization and cell polarization. Active 
Cdc42 has also been detected at the Golgi, but its role and regulation at this organelle are 
only partially understood. Here we analyze the spatial distribution of Cdc42 activity by moni­
toring the dynamics of the Cdc42 FLARE biosensor using the phasor approach to FLIM­FRET. 
Phasor analysis revealed that Cdc42 is active at all Golgi cisternae and that this activity is 
controlled by Tuba and ARHGAP10, two Golgi­associated Cdc42 regulators. To our surprise, 
FGD1, another Cdc42 GEF at the Golgi, was not required for Cdc42 regulation at the Golgi, 
although its depletion decreased Cdc42 activity at the PM. Similarly, changes in Golgi 
morphology did not affect Cdc42 activity at the Golgi but were associated with a substantial 
reduction in PM­associated Cdc42 activity. Of interest, cells with reduced Cdc42 activity at 
the PM displayed altered centrosome morphology, suggesting that centrosome regulation 
may be mediated by active Cdc42 at the PM. Our study describes a novel quantitative 
approach to determine Cdc42 activity at specific subcellular locations and reveals new regula­
tory principles and functions of this small GTPase.
INTRODUCTION
Tight spatial regulation of the small Rho GTPase Cdc42 is required 
for many cellular processes, including cell polarity, cell survival, ad-
hesion, migration, cell cycle progression, and membrane trafficking 
(Coso et al., 1995; Nobes and Hall, 1995; Kroschewski et al., 1999; 
Etienne-Manneville and Hall, 2001). Each of these functions de-
pends on regulated localization and activation of Cdc42, which is 
achieved through its recruitment to a specific cellular membrane. 
Membrane association of Cdc42 is necessary for its activation and 
requires the modification of its C-terminal end with a geranylgeranyl 
anchor (Michaelson et al., 2001). Activation is catalyzed by guanine 
nucleotide exchange factors (GEFs) and guanine nucleotide disso-
ciation inhibitors (GDIs), which assist in the translocation between 
the membrane and cytosol (Ku et al., 2001; Michaelson et al., 2001; 
Salazar et al., 2003; Egorov et al., 2009). Membrane trafficking has 
also been found to be critical for control of Cdc42 localization and 
activation (Osmani et al., 2010).
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Fluorescence lifetime imaging (FLIM) is a powerful method to 
measure FRET. It detects the specific rate of fluorescence decay, or 
lifetime, of only the donor fluorophore, which is constant unless an 
acceptor fluorophore is close enough to absorb the emitted en-
ergy, for example, when FRET occurs (Elangovan et al., 2002). 
FLIM is superior to traditional intensity-based ratiometric methods 
because it eliminates fluorescence artifacts inherent to biosensor 
design, which may lead to false measurements of Rho GTPase 
activity (Wallrabe and Periasamy, 2005; Hinde et al., 2012). For 
example, FRET detection by FLIM eliminates the effects of varia-
tions in biosensor concentration on activity measurements (Hinde 
et al., 2012). FLIM measurements also avoid issues with spectral 
bleedthrough, channel alignment, and photobleaching (Chen 
et al., 2003; Wallrabe et al., 2006). Because the fluorescence life-
time is sensitive to changes in the cellular environment, FLIM can 
be performed in living cells, which avoids fixation artifacts 
(Michaelson et al., 2001; Chen et al., 2003; Wallrabe and Pe-
riasamy, 2005). In addition, FLIM can readily differentiate between 
different fluorophore species and generate quantitative maps 
showing the average fraction of molecules at a given location that 
are undergoing FRET (Hinde et al., 2012).
FLIM data can be readily analyzed using the phasor approach, 
which describes the transformation of the numerous exponential 
fluorescence decay curves of each pixel into a two-dimensional 
plot called the phasor plot (Digman et al., 2008). This transforma-
tion plots each pixel to a unique place on the phasor plot accord-
ing to lifetime. Because the phasor plot is directly linked to the 
image, it allows the mapping of the lifetimes back to the image to 
provide a clear view of spatial changes in lifetime within the image. 
Overall, the phasor approach to FLIM simplifies the analysis of 
large FLIM data sets and provides a global view of FLIM data 
inside a cell.
This study aimed at identifying factors that control Cdc42 activity 
at the Golgi. Using the phasor approach to FLIM-FRET, we show 
that the activity of Cdc42, which was present throughout the Golgi, 
was regulated by ARHGAP10 and Tuba but not FGD1. Although 
Cdc42 activity at the Golgi was independent of Golgi structure, a 
connected Golgi ribbon was necessary for Cdc42 activity at the 
plasma membrane (PM). Finally, we found that Cdc42 activity at the 
PM, not the Golgi, contributed to the control of centrosome organi-
zation and function.
RESULTS
Spatial detection of Cdc42 activity using the phasor 
approach to FLIM­FRET
We generated a stable cell line expressing the Cdc42-FLARE bio-
sensor, which employs the cerulean/YPet FRET pair in a dual-chain 
design (donor fluorophore on the N-terminus of Cdc42, acceptor 
fluorophore YPet on the CRIB domain of the Cdc42 effector N-
WASP; Figure 1A). To avoid excessive expression of the biosensor 
and achieve similar expression levels in all cells, we generated a 
stable clonal U2OS (human osteosarcoma) cell line that expresses 
Cdc42-FLARE from an inducible promoter. Induction for 48 h 
resulted in expression levels of the biosensor that were about 
eightfold higher than those of endogenous protein (Supplemen-
tal Figure S1A) but did not affect cell morphology or function 
(Supplemental Figures S1B and S2). The imaging cell line also 
constitutively expressed the Golgi protein mannosidase II (ManII) 
fused to mCherry to label the medial-Golgi cisternae (Figure 1B). 
We routinely induced this imaging cell line for 48 h, which led to 
an enrichment of cerulean-Cdc42 at the Golgi, as previously re-
ported (Erickson et al., 1996; Michaelson et al., 2001). To evaluate 
Cdc42 is proposed to be a functional component of the Golgi. 
The localization of this small GTPase to the Golgi was detected with 
diverse methods, including fractionation, immunofluorescence, and 
electron microscopy (Erickson et al., 1996; Luna et al., 2002; Matas 
et al., 2004; Osmani et al., 2010). Golgi-associated Cdc42 is active, 
as observed directly through biosensor experiments and indirectly 
through visualization of the Cdc42 effectors Arp2/3 and N–Wiskott–
Aldrich syndrome protein (N-WASP) at the Golgi (Luna et al., 2002; 
Nalbant et al., 2004; Dubois et al., 2005; Baschieri et al., 2014). 
Cdc42 at the Golgi has been implicated in typical Golgi functions 
because disrupting its activity caused defects in protein transport 
through the Golgi (Wu et al., 2000; Luna et al., 2002; Egorov et al., 
2009; Hehnly et al., 2009; Park et al., 2015). It has also been linked 
to the regulation of centrosome organization and function (Kodani 
et al., 2009). However, it is not clear whether the Golgi-associated 
pool of Cdc42 is controlling these processes because it has not 
been possible to selectively disrupt the activity of this specific pro-
tein population.
Several factors have been implicated in the regulation of Cdc42 
activity at the Golgi. Two Cdc42-specific GEFs, Tuba and FGD1, 
are reported to localize to the Golgi. Tuba was observed at the 
Golgi in rat brain cryosections and in the perinuclear region of 
HeLa cells (Salazar et al., 2003; Kodani et al., 2009), and FGD1 lo-
calized to the trans-Golgi of HeLa, COS-7, and MC3T3 osteoblasts 
(Estrada et al., 2001; Egorov et al., 2009). Golgi membranes also 
host the Cdc42-specific GTPase-activating protein (GAP) ARH-
GAP10 (Dubois et al., 2005). In addition, GM130 and coronin7, 
two resident Golgi proteins without typical GEF and GAP domains, 
are proposed to contribute to Cdc42 regulation at the Golgi 
(Kodani et al., 2009; Bhattacharya et al., 2016). Biochemical assays 
in total cell lysates showed that GM130 controls ∼50% of cellular 
Cdc42 activity (Kodani et al., 2009). This peripheral Golgi protein 
is proposed to contribute to Cdc42 regulation by binding and 
sequestering RasGRF2, a Ras GEF that binds inactive Cdc42 at the 
plasma membrane (Calvo et al., 2011; Baschieri et al., 2014). 
Coronin7, in contrast, may limit Cdc42 activity at the Golgi. Its loss 
resulted in excessive N-WASP–mediated actin polymerization at 
the Golgi and a disrupted Golgi phenotype (Bhattacharya et al., 
2016). In spite of these studies, it remains unclear whether these 
regulatory proteins actually contribute to the control of Cdc42 
activity at the Golgi.
Several methods have been developed to detect intracellular 
Cdc42 activity. Biochemical assays, such as the PAK-CRIB binding 
assay, reveal the level of Cdc42 activity in total cell lysates (Benard 
and Bokoch, 2002). They use specific effector domains to isolate 
activated, GTP-bound Cdc42 molecules but have the disadvantage 
of not providing any spatial information. Förster resonance energy 
transfer (FRET) biosensors provide spatial information on the activity 
of small GTPase such as Cdc42 inside a cell (Machacek et al., 2009; 
Kunida et al., 2012; Nalbant et al., 2004; Itoh et al., 2002). However, 
the commonly used Cdc42 biosensors have limitations. The 
MeroCBD probe described by Nalbant et al. (2004) is an elegant 
tool to study Cdc42 activity in living cells but requires synthesis of 
dyes and cell loading through microinjection. Although this probe 
has demonstrated the presence of active Cdc42 at the Golgi, it is 
impractical for routine use. Genetically encoded FRET biosensors 
are easier to use because they can be expressed transiently or sta-
bly. In the Cdc42 FLARE biosensor used here, the Cdc42 C-terminus 
is free to interact with GDI and undergo the geranylgeranyl modifi-
cation that is essential for physiologically correct regulation of its 
activity (Michaelson et al., 2001; Itoh et al., 2002; Machacek et al., 
2009; Hanna et al., 2014).
Volume 28 July 15, 2017 Control of Cdc42 activity at the Golgi | 2137 
enough to allow an interaction between these two proteins and 
fairly constant between samples (unpublished data). For this en-
tire study, we focused on cells with a maximum of one to three 
neighboring cells, so the majority of its PM was not in contact with 
other cells.
donor and acceptor concentrations under these experimental 
conditions, we analyzed cells by cross-raster image correlation 
spectroscopy (ccRICS), a fluctuation method that detects protein 
complexes that are mobile and diffusing together. ccRICS re-
vealed that donor and acceptor protein concentrations were high 
FIGURE 1: Cdc42 activity inside a cell can be visualized with the phasor approach to FLIM-FRET. (A) Dual-chain 
biosensor Cdc42-FLARE with the FRET pair cerulean-Cdc42 and YPet-CBD in its inactive and active state. (B) The stable 
U2OS-Cdc42-FLARE cell line, which inducibly expresses Cdc42-FLARE while constitutively expressing ManII-mCherry, 
was left uninduced (top) or induced with cumate for 48 h (bottom). Confocal images of representative cells. (C) Intensity 
and FLIM maps of a control cell, which expresses the cerulean donor alone, or a U2OS-Cdc42-FLARE cell after induction 
for 48 h. The intensity maps (top) use a blue (low intensity) to red (high intensity) scale to show the distribution of 
cerulean (left) or cerulean-Cdc42 (right). The FLIM maps (middle) show the active population of the biosensor in the 
range from 0% (white) to a maximal FRET of 28% (magenta), as calculated from the cerulean lifetimes through the 
phasor plot shown in D. (D) Phasor plot of the distribution of cerulean lifetimes for the cells from C with the 
superimposed theoretical FRET trajectory, calculated with the SIM-FCS software. (E) FLIM-FRET analysis of Cdc42 
activity in nonmigrating and migrating cells. U2OS-Cdc42-FLARE imaging cells, after cumate induction for 48 h, were 
left untreated (left) or incubated with PDGF to stimulate migration (right). Intensity maps of cerulean-Cdc42 are shown, 
as well as FLIM maps that reflect the fraction of the active Cdc42 population. The graphs show a quantification of the 
percentage of active Cdc42 molecules in the top or bottom half of unstimulated and stimulated cells.
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maximal detected FRET efficiency was 28% for our experimental 
conditions (Figure 1D). Given that this biosensor is either on or off, 
the line that connects the high FRET (“on”) state to the no FRET 
(“off”) state of the phasor describes the fractional population of the 
active biosensor. In this study, the results are reported as the fraction 
of active Cdc42 molecules, with 0% showing no active small GTPase 
and 100% indicating the highest detectable fraction of active Cdc42. 
Cerulean-Cdc42 was enriched in the perinuclear region of Cdc42-
FLARE–expressing cells, where it colocalized with the Golgi marker 
ManII-mCherry (Figure 1C, right). In these cells, the fraction of active 
Cdc42 molecules was highest at the Golgi and PM compared with 
the rest of the cell (Figure 1D; Hinde et al., 2012). These data are 
consistent with reports by the Hahn lab with the MeroCBD bio-
sensor, which detected activity of endogenous Cdc42 at the Golgi in 
nonpolarized cells (Nalbant et al., 2004).
We validated our assay by monitoring Cdc42 activity at the lead-
ing edge of polarized cells, a well-established site of active Cdc42 
(Nalbant et al., 2004; Monypenny et al., 2009; Hanna et al., 2014). 
We stimulated cell polarization and migration in collagen I–coated 
chemotaxis chambers using platelet-derived growth factor (PDGF) 
and performed FLIM-FRET measurements. As expected, there was 
high FRET at the leading edge of the cell 
(arrow) during cell migration, which was ab-
sent from unstimulated control cells (Figure 
1E and Supplemental Figure S3). Similarly, 
higher levels of FRET were also detected 
throughout cells that transiently expressed 
a constitutively active form of the Cdc42-
FLARE biosensor compared with the wild-
type biosensor (Supplemental Figure S4).
We next monitored Cdc42 activity at indi-
vidual Golgi cisternae. We generated addi-
tional U2OS cell lines that inducibly ex-
pressed Cdc42-FLARE together with low 
levels of specific cis- or trans-Golgi markers 
(Figure 2A). To increase the resolution at the 
Golgi, we focused on a 25.29 × 25.29 µm2 
region (∼100 nm/pixel), which we found to 
be the smallest area to contain most Golgi 
membranes. Cdc42-FLARE was enriched at 
the Golgi in each of the cell lines. To isolate 
Cdc42 activity at each individual Golgi cis-
ternae, we overlaid the FLIM data with a 
mask of Golgi cisternae–specific markers, 
which we generated by thresholding images 
of mApple-p58, ManII-mCherry, or GalT-
mCherry recorded in parallel. This approach 
revealed similar average fractions of active 
Cdc42 of 76.98, 74.13, and 73.8% at the cis-
Golgi (mApple-p58), medial-Golgi (ManII-
mCherry), and trans-Golgi (GalT-mCherry), 
respectively. The signal at the Golgi was spe-
cific because the fraction of active Cdc42 at 
the Golgi was significantly higher than in ran-
domly selected areas in the cytosol at half 
the distance between the Golgi and the PM 
and that did not overlap with the Golgi area 
(Figure 2B). These experiments show that 
the Cdc42-FLARE biosensor with the phasor 
approach to FLIM-FRET is capable of detect-
ing enrichment in active Cdc42 at the lead-
ing edge and all Golgi cisternae.
Inducible expression of Cdc42-FLARE did not alter cell morphol-
ogy and behavior. A comparison of wild-type U2OS and uninduced 
and induced U2OS-Cdc42-FLARE cells in an immunofluorescence 
analysis showed no difference in the organization of the endoplas-
mic reticulum (ER), Golgi, and cytoskeleton (Supplemental Figure 
S1B). In addition, Cdc42-dependent functions, such as anterograde 
and retrograde protein transport at the Golgi, as well as filopodia 
formation, were unaffected by expression of this biosensor (Supple-
mental Figure S2, A and B). Finally, the organization of the centro-
some, which we reported to be altered in cells with reduced Cdc42 
activity, was normal (Supplemental Figure S1B; Kodani et al., 2009).
We used the phasor approach to FLIM-FRET to detect the activ-
ity of this biosensor at the Golgi and the PM. We first defined the 
range of FRET efficiencies in cells. The intensity map of cells express-
ing cerulean in the absence of an acceptor showed greater intensity 
in the center of the cell (Figure 1C, left, blue-to-red scale). Because 
FLIM is independent of fluorophore concentration, the fluorescence 
lifetime of cerulean was uniform (Figure 1C, middle), corresponding 
to ∼2.8 ns on the universal semicircle of the phasor plot (Digman 
et al., 2008), and was quenched to a maximum of ∼1.9 ns. The ellipti-
cal trajectory shown in the phasor plot coordinates indicates that the 
FIGURE 2: FLIM-FRET measurements detect Cdc42 activity at the Golgi. (A) Cdc42 activity 
measurements in a 25.29 × 25.29 µm2 square containing the cis-, medial-, or trans-Golgi 
cisternae in U2OS-Cdc42-FLARE imaging cell lines constitutively expressing p58-mApple, 
ManII-mCherry or GalT-mCherry, respectively (left). Intensity maps for cerulean-Cdc42 and YPet 
in this region (middle two) are also shown. The percentages of active Cdc42 at specific Golgi 
cisternae were determined by overlaying FLIM maps with thresholded images of each Golgi 
marker (right). Graph shows the average percentage of active Cdc42 at each Golgi cisternae 
from eight cells per experiment and three independent experiments. (B) A comparison of Cdc42 
activity at the Golgi and a random area in the cytosol. For a representative U2OS-Cdc42-FLARE 
imaging cell, the cerulean intensity (left) and the FLIM map (middle) are shown for the entire cell. 
Expression of ManII-mCherry (right) was used to mark the Golgi so that the specific FLIM signal 
at this location could be extracted. The position of the area in the cytosol (11.8 × 11.8 µm2, 
halfway between the perinuclear region and the PM) is shown as boxes in the intensity and FLIM 
maps. Scale bar, 10 µm. Graph shows the average percentage of active Cdc42 at the Golgi or in 
the cytosol from 8–12 cells per experiment and three independent experiments. *p < 0.0001.
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We performed a similar analysis for Golgi-localized Cdc42 GEF 
FGD1 (Estrada et al., 2001), which was found to be necessary for 
Golgi-to-PM transport (Egorov et al., 2009). To our surprise, the frac-
tion of active Cdc42 at the Golgi was similar in control and FGD1-
depleted cells—74.28 and 73%, respectively. However, there was a 
reduction in the percentage of active Cdc42 at the PM from 73.9% 
in control cells to 51.9% in FGD1-depleted cells (t(36) = 5.8322, p < 
0.0001; Figure 4B and Supplemental Figure S6). Thus, in spite of its 
Golgi association, this Cdc42 GEF does not appear to contribute to 
Cdc42 activation at the Golgi. For this entire set of experiments, we 
verified that our manipulations did not affect fluorescence intensi-
ties of donor and acceptor proteins (Supplemental Figure S6).
Ribbon­like Golgi organization is important for Cdc42 
activation at the PM
We next measured Cdc42 activity in cells with altered Golgi organi-
zation. The Golgi ribbon was reported to be maintained by the 
structural Golgi protein GM130, with GM130 loss leading to discon-
nected Golgi stacks (Puthenveedu et al., 2006). GM130 was de-
pleted from the U2OS-Cdc42-FLARE imaging cell lines, followed by 
Cdc42 activity measurements with our FLIM-FRET assay. We then 
fixed the cells and stained them with an antibody to GM130 to 
confirm protein depletion in the cells that we had imaged. To our 
surprise, the fractions of active Cdc42 at the Golgi were similar in 
control and GM130-depleted cells—70.4 and 71.8%, respectively 
(Figure 5A and Supplemental Figure S7). However, at the PM of 
these cells, there was a significant decrease in the fraction of active 
Cdc42, from 69.0 to 50.8% (t(40) = 8.9123, p < 0.0001), which was 
not observed in control cells. This effect was specific and not due to 
reduced levels of donor or acceptor molecules (Supplemental 
Figure S7). This result suggests that either GM130 or Golgi ribbon 
organization is important for Cdc42 activation at the PM.
To differentiate between these possibilities, we analyzed cells 
with an extensively fragmented Golgi. We focused on golgin-84, a 
structural Golgi protein whose loss leads to Golgi fragmentation, 
dispersal, and a reduction in protein transport (Diao et al., 2003). 
Control and golgin- 84–depleted cells 
showed similar FRET percentages at the 
Golgi (Figure 5B and Supplemental Figure 
S7) but not at the PM, where golgin-84 de-
pletion caused a decrease in the fraction of 
active Cdc42 from 69.82 to 45.17% (t(38) = 
11.1093, p < 0.0001). These results suggest 
that Cdc42 activation at the Golgi is inde-
pendent of Golgi organization but that dis-
ruption of Golgi organization prevents 
Cdc42 activation at the PM.
Cdc42 controls centrosome 
organization from the PM
We next tested whether Cdc42 activity at 
the PM is critical for the regulation of the 
centrosome. We previously reported cen-
trosome abnormalities in cells in which total 
cellular Cdc42 activity was reduced through 
depletion of GM130 or Tuba or overexpres-
sion of dominant-negative Cdc42 (Kodani 
et al., 2008, 2009). We focused our analysis 
on FGD1- and golgin-84–depleted cells 
because they displayed reduced Cdc42 ac-
tivity only at the PM (Figures 4 and 5). As a 
readout for centrosome organization, we 
Golgi­associated Cdc42 regulators have differential roles in 
controlling Cdc42 activity at the Golgi
We used the U2OS-Cdc42-FLARE cell line to investigate the role of 
the Golgi-associated GAP ARHGAP10 in the regulation of Cdc42 
activity at the Golgi. This protein has been implicated in Cdc42 
regulation at the Golgi through indirect measurements of protein 
transport (Dubois et al., 2005). Consistent with published data, a 
truncated form that only contains the PH and GAP domains but 
lacks the PM targeting domain localized to the Golgi in our imaging 
cell line (Figure 3A and Supplemental Figure S5; Dubois et al., 
2005). FLIM-FRET analysis in cells expressing this construct revealed 
a significant decrease in Cdc42 activity at the Golgi, with a reduction 
in the percentage of active Cdc42 from 71.46 to 49.2% (t(52) = 
18.1771, p < 0.0001; Figure 3B). This reduction was not due to ef-
fects on donor or acceptor levels because fluorescence intensities of 
these proteins were similar in both samples (Supplemental Figure 
S5). We conclude that the Golgi-associated pool of ARHGAP10 is 
able to inactivate Cdc42 at the Golgi and provide the first direct evi-
dence that manipulations of a Cdc42 regulator lead to a decrease in 
Golgi-associated Cdc42 activity.
We next examined whether activation of Cdc42 at the Golgi de-
pends on Tuba, which is reported to associate with the Golgi and 
the PM. We transfected U2OS-Cdc42-FLARE imaging cells with 
either control (scrambled) or Tuba-specific small interfering RNA 
(siRNA) and collected FLIM data at the Golgi, which was marked by 
ManII-mCherry. We also collected FLIM data at the PM, which was 
labeled by expression of the PM marker mApple-farnesyl. For this 
experiment, we zoomed in on the PM to the same extent as the 
Golgi, focusing on a region of the PM not in contact with other cells. 
After data collection, we verified protein loss in the cells that we had 
imaged through immunofluorescence analysis on gridded dishes 
(Supplemental Figure S6). Tuba-depleted cells contained a much 
smaller fraction of active Cdc42 at the Golgi and the PM than control 
cells, with decreases from 72.7 to 52.1% (t(52) = 9.9833, p < 0.0001) 
and 70.2 to 49.9% (t(56) = 14.9569, p < 0.0001), respectively (Figure 
4, A and B).
FIGURE 3: ARHGAP10 controls Cdc42 activity at the Golgi. A construct encoding for a 
myc-tagged ARHGAP10 truncation consisting of the PH and GAP domains, which mediate Golgi 
localization, was transfected into the U2OS-Cdc42-FLARE imaging cell line that constitutively 
expresses ManII-mCherry. The percentages of active Cdc42 were determined with the phasor 
approach to FLIM-FRET, as described in Figure 1. (A) For each cell that was analyzed by 
FLIM-FRET, the association of the ARHGAP10 truncation with the Golgi (marked by ManII-
Cherry) was verified through immunofluorescence staining with antibodies to myc. (B) Average 
percentage of active Cdc42 at the Golgi from cells that either express an empty vector (Cont.) 
or Golgi-targeted ARHGAP10. At least eight cells were analyzed per experiment, and three 
independent experiments were performed. *p < 0.0001.
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We used novel tools to map Cdc42 activity in living cells. We 
established stable U2OS imaging cell lines for Cdc42 activity mea-
surements, which inducibly expressed the Cdc42-FLARE biosensor. 
These imaging cell lines also expressed Golgi and PM markers, 
which facilitated measurement of Cdc42 activity at these specific 
locations at high pixel resolution (25.29 × 25.29 µm2; ∼100 nm/
pixel). We measured FRET with the phasor approach to FLIM in live 
cells, which allowed us to obtain quantitative measures of Cdc42 
activity at specific cellular locations. There were approximately four 
times more active Cdc42 molecules at the Golgi than in randomly 
selected areas in the cytosol.
FLIM-FRET is highly suitable for this study because artifacts that 
are either caused by sample fixation or inherent to ratiometric FRET 
measurements were avoided. It also allowed for the detection of 
Cdc42 activity in areas with low biosensor expression levels. This 
became evident in migration experiments, in which the increase in 
the percentage of active Cdc42 molecules at the leading edge was 
not caused by a change in cerulean-Cdc42 intensity.
Our study is the first to provide direct support for the differential 
regulation of Cdc42 activity at the Golgi and PM in live cells. At the 
Golgi, Cdc42 activity was down-regulated when we expressed a 
Golgi-targeted form of ARHGAP10 or depleted Tuba. At the PM, 
Cdc42 activity was reduced when FGD1 was removed or Golgi 
monitored the centrosomal protein kendrin, which reveals centro-
some abnormalities in cells with reduced Cdc42 activity (Kodani 
et al., 2009). Whereas control cells displayed the typical comple-
ment of two to four centrioles, there were aberrant kendrin foci 
next to the centrioles in FGD1- and golgin-84–depleted cells 
(Figure 6B, right). γ-Tubulin organization, in contrast, was unal-
tered, which is consistent with earlier reports (Kodani et al., 2009). 
Thus, because golgin-84– and FGD1-depleted cells phenocopied 
the centrosome defects of GM130-depleted cells (Figure 6, B 
and C), we conclude that Cdc42 activity at the PM, and not the 
Golgi, may be critical for the maintenance of proper centrosome 
organization.
DISCUSSION
This study provides new insights into the control of Cdc42 activity at 
different cellular locations. The use of a dual-chain FRET biosensor 
and the phasor approach to FLIM led to three novel findings with 
regard to the spatial regulation and function of Cdc42 activity. We 
show that 1) Golgi-associated Cdc42 activity is controlled by 
ARHGAP10 and Tuba but not FGD1 and GM130, 2) Cdc42 activity 
at the PM depends on an intact Golgi ribbon, and 3) PM-associated 
Cdc42 activity is critical for the organization and function of the 
centrosome.
FIGURE 4: Tuba, but not FGD1, regulates Cdc42 activity at the Golgi. 
FLIM-FRET analysis of cells lacking the Golgi-associated GEFs Tuba or 
FGD1. The U2OS-Cdc42-FLARE imaging cell line, which also 
expressed ManII-mCherry or mApple-farnesyl to label the Golgi or 
PM, respectively, was transfected with scrambled-, Tuba-, or FGD1-
specific siRNA and subjected to FLIM-FRET analysis at the Golgi or 
PM. Average percentage of active Cdc42 at the Golgi (left) or the PM 
(right). For each condition, eight cells were analyzed per experiment, 
and three independent experiments were performed. *p < 0.0001. 
(A) FLIM-FRET analysis of scrambled (Scr) and Tuba-depleted cells 
(Tuba). (B) FLIM-FRET analysis of scrambled (Scr) and FGD1-depleted 
cells (FGD1).
FIGURE 5: Cdc42 activity at the PM depends on normal Golgi 
organization. The phasor approach to FLIM-FRET was used to 
determine Cdc42 activity at the Golgi and PM after disruption of Golgi 
organization through depletion of GM130 and golgin-84. Cdc42 
activity measurements at the Golgi and PM were performed in induced 
U2OS-Cdc42-FLARE cells expressing ManII-mCherry or mApple-farne-
syl. Average percentage of active Cdc42 at the Golgi (left) and the PM 
(right). For each condition, eight cells were analyzed per experiment, 
and three independent experiments were performed. *p < 0.0001. 
(A) FLIM-FRET measurements of cells treated with control (Scr) or 
GM130-specific siRNA. (B) FLIM-FRET measurements of cells trans-
fected with scrambled (Scr) or golgin-84–specific siRNA (Golgin-84).
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aspect of Golgi function is required to acti-
vate Cdc42 at the PM because GM130 or 
golgin-84 depletion may interfere with pro-
tein modification, sorting, or transport of 
Cdc42 itself or a specific regulator. A mech-
anism involving post-Golgi transport would 
be consistent with previous findings on the 
requirement for membrane trafficking for 
Cdc42 activation at the leading edge of 
cells (Osmani et al., 2010).
Our results led to a revised model of 
Cdc42-mediated regulation of the centro-
some. We previously proposed that Cdc42 
activity at the Golgi controls centrosome 
organization because GM130-depleted 
cells displayed reduced Cdc42 activity in 
biochemical assays and centrosome de-
fects (Kodani et al., 2009). However, the 
spatial analysis of Cdc42 activity estab-
lishes a strong correlation between Cdc42 
activity at the PM and centrosome regula-
tion. Cells in which PM-associated Cdc42 
activity was specifically reduced—for ex-
ample, as a result of FGD1 or golgin-84 
depletion, displayed abnormal centrosome 
morphology, with an increased number of 
kendrin foci but normal γ-tubulin organiza-
tion. These experimental conditions had 
no effect on Cdc42 activity at the Golgi, 
suggesting that Golgi-associated Cdc42 
does not contribute to the regulation of 
this adjacent organelle. This revised model 
is consistent with previous findings on ab-
normal centrosomes in cells that either 
lacked Tuba or expressed dominant-nega-
tive Cdc42 (Kodani et al., 2009).
It is not known how PM-associated Cdc42 controls the centro-
some. A possible mechanism involves microtubules, which are 
necessary for centrosome assembly and whose dynamics depend 
on binding of activated Cdc42 to the PAR complex at the PM 
(Young et al., 2000; Etienne-Manneville and Hall, 2003). Consistent 
with this idea, microtubule depolymerization with low concentra-
tions of nocodazole caused changes in centrosome organization 
that phenocopied the depletion of GM130 or golgin-84 (Dammer-
mann and Merdes, 2002). Microtubule attachment to the PM also 
promotes tension, which helps position the centrosome (Burakov 
et al., 2003). Alternatively, active Cdc42 may contribute to the ac-
tivation of the PAR complex, possibly controlling the centrosomal 
localization of the PAR6 isoforms Par6α and Par6γ, which are nec-
essary for centrosome assembly (Kodani et al., 2010; Dormoy 
et al., 2013).
Baschieri et al. (2014) reported a role for GM130 in the control of 
Cdc42 activity at the Golgi, which contradicts our findings. They 
found that GM130-depleted HEK293T cells had reduced levels of 
active Cdc42 at the Golgi, whereas activity levels at the PM were 
unaffected. Their model suggests that GM130-mediated Cdc42 
regulation does not involve a GEF but, instead, GM130 binding to 
RasGRF2, a known negative regulator of the small GTPase Ras 
(Fernández-Medarde and Santos, 2011). There are several possible 
explanations for the discrepancies between our findings and those 
of Baschieri et al. (2014). For example, they used a single-chain 
biosensor in which the Rho GDI–binding site in Cdc42 is blocked. 
organization was disrupted. Of interest, these latter factors did not 
affect Cdc42 activity at the Golgi, suggesting that the population of 
Cdc42 activity at the Golgi is independent of its PM-associated 
counterpart. Only Tuba controlled activity at the Golgi and the PM, 
which is likely due to its presence at both locations. It remains un-
clear whether Golgi-associated Cdc42 activity affects the popula-
tion of this small GTPase at the PM.
The role of FGD1 at the Golgi is unclear. This GEF is reported 
to contribute to Cdc42 recruitment to the Golgi, but its depletion 
had no effect on the fraction of active, Golgi-associated Cdc42. It 
is possible that FGD1 at the Golgi may not be active or that it as-
sociates with inactive Cdc42. Alternatively, previous studies with 
FGD1 relied on overexpression of FGD1 mutants, which may have 
affected FGD1 function at the Golgi (Egorov et al., 2009). Although 
additional experiments are needed to better understand the 
Golgi-associated pool of FGD1, our results demonstrate a role for 
this GEF at the PM, which is consistent with the reported reduction 
of Cdc42 activity in total lysates of FGD1-depleted cells (Egorov 
et al., 2009).
Of interest, Cdc42 activity at the PM depended on an intact 
Golgi ribbon. We manipulated Golgi organization in two ways. We 
removed GM130, which leads to disconnected Golgi ministacks, 
glycosylation defects, and delayed protein transport (Puthenveedu 
et al., 2006; Marra et al., 2007). We also depleted golgin-84, which 
induces extensive Golgi fragmentation and a general reduction in 
protein transport (Diao et al., 2003). We do not yet know which 
FIGURE 6: Active Cdc42 at the PM is necessary for the control of normal centrosome 
organization. (A) Western blot of total cell lysates from U2OS cells transfected with scrambled 
siRNA as a negative control (left) or siRNA specific to FGD1, golgin-84, or GM130 for 48 h 
(right). α-Tubulin and glyceraldehyde 3-phosphate dehydrogenase served as loading controls. 
(B) Cells from A were analyzed by immunofluorescence with antibodies to the centrosomal 
proteins γ-tubulin and kendrin. Left, merged imaged in which γ-tubulin is in red, kendrin in green, 
and DNA, as stained with Hoechst 33342, in blue. Scale bar, 10 µm. (C) Percentage of control, 
FGD1-, golgin-84–, and GM130-depleted cells displaying more than four centrosomal foci (three 
independent experiments, with >300 cells counted per condition and per experiment).
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the Suetterlin lab) was inserted between EcoRI/NotI of PB-EF1-
MCS-IRES-Neo. PB-GalT-mCherry: mCherry cDNA was inserted be-
tween NheI/NotI in PB-EF1-MCS-IRES-Neo; then GalT cDNA was 
PCR amplified from pYFP-GalT (a generous gift from John Presley, 
McGill University, Montreal, Canada; Yilmaz Dejgaard et al., 2007) 
and inserted between SacII/NotI 5′ of the mCherry cDNA. PB-
mApple-p58: mApple cDNA (a generous gift from Michael David-
son, Florida State University, Tallahassee, FL; Kremers et al., 2009) 
was first inserted between NheI/EcoRI of PB-EF1-MCS-IRES-Neo; 
then p58 cDNA was PCR amplified from pYFP-p58 (a generous gift 
from John Presley; Yilmaz Dejgaard et al., 2007) and inserted into 
EcoRI downstream of mApple using the Cold Fusion kit (Systems 
Biosciences). ARHGAP10-myc: The fragment encoding for amino 
acids 885–1346 of ARHGAP10, which contains the PH and GAP do-
mains, was amplified from the KIAA1424 template (Nagase et al., 
2000) and cloned into the EcoRI site of PCDNA3.1+.
RNA interference
Protein depletion was carried out by transfecting U2OS cells (HTB96; 
American Type Culture Collection [ATCC]) with 200 nM (GM130, gol-
gin-84, and scrambled) or 50 nM (Tuba, FGD1, and scrambled) siRNA 
duplexes using Oligofectamine as described by the manufacturer. 
The following sequences were used to target GM130: 5′-AAGT-
TAGAGAGATGACGGAACTC-3′ (Puthenveedu et al., 2006), Tuba: 
5′-GAGCTTGAGGGAACATACAAGATTT-3′ (Kodani et al., 2009), gol-
gin-84: 5′-AAGTAGGATCTCGGACACCAG-3′ (Diao et al., 2003), 
FGD1-Smartpool (M-009612-01-0005; Dharmacon), and a scrambled 
control sequence, 5′-AAACTAAACTGAGGCAATGCC3′ (Sutterlin 
et al., 2005). All siRNA duplexes were obtained from Life Technolo-
gies unless noted otherwise.
Antibodies
Primary antibodies to the following proteins were used in this 
study: calreticulin (C4606; Sigma-Aldrich), Tuba (a gift from Frank 
Gertler, MIT; and B01P, Abnova), centrin2 (a gift from Jeffery L. 
Salisbury, Mayo Clinic; and Clone 20H5, Millipore), FGD1 (HPA 
000911; Sigma-Aldrich), myc (Clone 9E10; Cal Biochem), GM130 
(Clone 35; BD Biosciences; and G7295, Sigma-Aldrich), giantin (a 
gift from Vivek Malhotra, Center for Genomic Regulation, Barce-
lona, Spain), kendrin (a gift from Mikiko Takahashi, Teikyo Heisei 
University), α-tubulin (T5168; Sigma-Aldrich), γ-tubulin (ab11310; 
Abcam), Cdc42 (Clone 44; BD Biosciences), and vesicular stomati-
tis virus G-protein (VSVG; BWG85; a gift from Victor Hsu, Harvard 
Medical School). Secondary antibodies for immunofluorescence 
were from Theromo Fisher or Biotium, and near-infrared antibodies 
for Western blots were from LI-COR (Lincoln, NE). For immunofluo-
rescence, cells were fixed in either 100% ice-cold methanol (JT 
Baker) or 4% formaldehyde (Ted Pella), blocked and permeabilized 
with 2% blocking buffer (2% fetal bovine serum [FBS], 0.01% Triton 
X-100, and 1× phosphate-buffered saline), stained with primary an-
tibodies for 1 h at room temperature, and stained with secondary 
antibodies for 1 h. Coverslips were mounted with ProLong Gold 
(Thermo Fisher), and imaging dishes were filled with Ibidi Mount-
ing Medium (Ibidi).
Cell culture, establishment of stable cell lines, and protein 
expression
Parental U2OS cells (HTB96; ATCC) and all derived clonal cell lines 
were cultured in Advanced DMEM supplemented with 10% FBS (Hy-
clone) and 2 mM GlutaMAX-I (GIBCO, Rockville, MD) at 37°C with 
5% CO2. Stable cell lines were generated using the PB transposon 
system (System Biosciences). In brief, U2OS cells were cotransfected 
However, the GDI–Cdc42 interaction was recently found to be criti-
cal for the spatiotemporal regulation of Cdc42 activity (Hodgson 
et al. 2016). Furthermore, they performed FRET measurements with 
the acceptor photobleaching method after cell fixation, which is 
reported to affect small GTPase localization (Michaelson et al., 
2001). In addition, they relied on the expression of their Cdc42 
biosensor to mark the Golgi instead of labeling it with a specific 
marker. Finally, they used different cell lines, with depletions of 
GM130 and the various Cdc42 GEFs in HEK293T but experiments 
with RasGRF in HeLa cells.
In our study, in contrast, we detected the fractional population of 
active Cdc42 at the Golgi and the PM in living U2OS cells, using a 
dual-chain biosensor that maintains GDI binding, and measured 
FRET with the phasor approach to FLIM. Focus in our study was 
given to the specific locations of our FRET measurements, which 
were determined through coexpression of markers and only on cells 
in which manipulations were confirmed. Attempts to corroborate 
the results of Baschieri et al. (2014) were unsuccessful. We were 
unable to detect RasGRF2 in U2OS and HeLa cells by immunofluo-
rescence or Western blot with the reported antibody (sc-863 C18; 
Santa Cruz Biotechnology) or two other commercial antibodies 
(sc-224 C-20, ProteinTech; 19717-1-AP; Santa Cruz Biotechnology; 
unpublished data). We also failed to deplete RasGRF2 from HeLa or 
U2OS cells with the reported siRNA (SI04235147; Qiagen). Thus 
better reagents have to be developed to resolve the discrepancies 
between these two studies.
In conclusion, we used the phasor approach to FLIM-FRET and a 
biosensor with an intact GDI interaction domain to demonstrate for 
the first time how manipulations of cellular factors, including GEFs, 
GAPs, and structural Golgi proteins, affect Cdc42 activity at the 
Golgi and the PM in live cells. Future studies will focus on under-
standing how Golgi organization and/or function controls Cdc42 
activation at the PM and how active Cdc42 at the PM in turn regu-
lates the centrosome. The assay and cell lines that we developed 
will help develop a comprehensive model of Cdc42 regulation at 
the Golgi, the PM, and other cellular locations.
MATERIALS AND METHODS
Molecular biology
The Cdc42-FLARE biosensor was based on the dual-chain biosen-
sors described in Machacek et al. (2009). Cerulean fluorescent pro-
tein (CFP; Rizzo et al., 2004) replaced CyPet to improve brightness 
and FRET efficiency, and residues 201–293 of WASP were used as 
the affinity reagent. The two biosensor chains were expressed on 
one open reading frame with two consecutive 2A viral peptide se-
quences from porcine teschovirus-1 (P2A) and Thosea asigna virus 
(T2A) inserted between them, leading to the production of  two 
chains during translation (Kim et al., 2011). The biosensor is under-
going further optimization, which will be described in detail in a 
separate publication. For the establishment of stable Cdc42-FLARE 
cell lines, we used the PiggyBac (PB) all-in-one cumate expression 
system PB-Cuo-MCS-IRES-GFP-EF1-CymR-Puro (PBQM812A-1; 
Systems Biosciences) and EF1 constitutive active expression system 
PB-EF1-MCS-IRES-Neo (PB533A-2; Systems Biosciences). The con-
structs were generated as follows: PB-CuRo-MCS-EF1-CymR-Puro: 
PB-Cuo-MCS-IRES-GFP-EF1-CymR-Puro was digested with XcmI/ 
AvrII to release IRES-GFP, followed by a Klenow and religation. PB-
Cdc42-FLARE: the Cdc42-FLARE fragment was released from 
pTriEx-myc-Ypet–Cdc42-binding domain (CBD)-P2A-T2A-Flag-Cer-
Cdc42 (provided by Klaus Hahn, University of North Carolina) with 
NheI/BstBI and inserted between NheI/ClaI of PB-Cuo-MCS-EF1-
CymR-Puro. PB-ManII-mCherry: ManII-mCherry cDNA (available in 
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(Hinde et al., 2012). In brief, files were calibrated against the couma-
rin 6 control, which has a known lifetime of 2.6 ns. The fluorescence 
lifetime of each pixel of the image was then mapped to the phasor 
plot. The lifetime of the cerulean in control cells and the autofluores-
cence signal were set on the phasor, and the FRET calculator in 
SimFCS was used to generate the FRET trajectory for mapping ac-
tivity in cells. These measurements revealed a maximal detectable 
FRET efficiency of 28% for this biosensor. This maximal FRET effi-
ciency was defined as 100% of the active Cdc42 population. Given 
that all of the FLIM images were collected for both donor and ac-
ceptor emission using a pixel of ∼100 nm, ccRICS was performed 
with SimFCS to demonstrate that donor and acceptor proteins inter-
acted in the selected regions of interest in biosensor-expressing 
cells. The cross-correlation method detects molecules of the two 
colors (donor and acceptor) diffusing together, also referred to as 
dynamic colocalization. In principle, cross-correlation does not dem-
onstrate FRET but only that a complex is formed. In addition, the 
RICS method is sensitive to only diffusing molecules, with immobile 
molecules in the same pixel not contributing to the cross-correlation 
signal.
For intensity measurements, we used SimFCS to generate inten-
sity histograms (photon counts/frame/pixel) for representative cells 
for each experimental condition.
To determine the average percentage of active Cdc42 at a spe-
cific location, we imported images of the Golgi or PM marker taken 
at the time of live imaging into Fiji using BioFormats and subjected 
them to thresholding using the IsoData method for the Golgi or 
hand tracing with a 20-pixel overlay brush for the PM (Ridler and 
Calvard, 1978; Linkert et al., 2010; Schindelin et al., 2012). These 
images were then imported into SimFCS and used to mask the FLIM 
data for the corresponding cell at the Golgi and the PM. To analyze 
the data, analysis of variance was created with post hoc t tests in R 
software.
For polarized cells, cells were divided into two regions by draw-
ing a line through the nucleus perpendicular to the gradient (or 
where the gradient would have been in control cells) and then 
calculating the average Cdc42 activity for each region.
Protein transport
VSVGts045-myc or VSVG-KDELR (a generous gift from Jennifer 
Lippincott-Schwartz, National Institutes of Health; Cole et al., 
1998) was transiently transfected into wild-type U2OS or U2OS-
Cdc42-FLARE cells using X-treme Gene 9 and incubated at 37°C at 
5% CO2 for 18 h. Before transport experiments, medium was sup-
plemented with 25 µM 4-(2-hydroxyethyl)-1-piperazineethanesul-
fonic acid, pH 7.4. Cells were then incubated at 40.5°C for 4 h to 
accumulate VSVG in the ER, followed by a shift to the permissive 
temperature of 32°C to allow the protein to exit the ER. Cells were 
fixed in 4% formaldehyde (Ted Pella) at 0, 20, 60, or 120 min after 
shift to 32°C and processed for immunofluorescence analysis using 
an Axiovert 200 M microscope with AxioVision software (Zeiss). 
Cells with VSVG-KDELR were incubated for 2 h at 32°C to accumu-
late protein in the Golgi, followed by a shift to 37°C for 0, 2, 4, or 
6 h to permit retrograde transport the ER. Image analysis was done 
with ImageJ.
with a PB-transposon construct (PB-mApple-p58, PB-GalT-mCherry, 
PB-ManII-mCherry, PB-mApple-Farnesyl, or PB-Cdc42-FLARE) and 
PB-transposase using X-tremeGENE 9 (Roche) as described by the 
manufacturer. Cells were selected for integration of the transposon 
using G418 at 500 µg/ml or puromycin at 2 µg/ml (Gold Biotechnol-
ogy). Clonal cell lines were generated through serial dilution in 
96-well plates.
Expression Cdc42-FLARE was accomplished by incubating the 
cells with 300 µg/ml water-soluble cumate (Systems Bio Sciences) 
for 48 h. For transient transfections, DNA constructs were intro-
duced into cells using Lipofectamine 3000 (Life Technologies) or X-
treme Gene 9 according to manufacturer’s protocol.
FLIM­FRET experiment and analysis
Cell preparation. Inducible Cdc42-FLARE cell line was seeded in 
six-well dishes 60 h before imaging at 50% confluency. At 48 h 
before imaging, the cells were induced with 300 µg/ml cumate 
(Systems Biosciences), and cumate concentration was maintained 
constant throughout the experiment. For protein depletion assays, 
48 h before imaging, cells were transfected with RNAi using 
Oligofectamine. For protein expression, ∼18 h before imaging, 
cells were transiently transfected with ARHGAP10 constructs using 
Lipofectamine 3000 (Life Technologies) or the cerulean control 
using X-treme Gene 9. At 24 h before imaging, cells were 
transferred to a µDish35 mm, high with Grid-500 (81166; Ibidi), which 
was used for live imaging and locating the previously imaged cells 
after fixation.
Imaging. All FLIM experiments were done in living cells, which 
were maintained at 37°C with 5% CO2. After live imaging, cells were 
fixed, and the imaged cells were identified using the grid on the 
dish and analyzed using immunofluorescence to confirm protein de-
letion or expression. All data were acquired using a Zeiss LSM780 
laser scanning microscope equipped with an incubation chamber 
and coupled to a two-photon Ti:sapphire laser (Spectra-Physics) and 
an ISS A320 FastFLIM box to acquire the lifetime data. An LD C-
Apochromat 63×/1.15 water immersion objective (Zeiss) was used 
for all live-cell experiments, and a Plan-Apochromat 63×/1.40 Oil 
DIC was used for all fixed experiments. Cerulean was excited at 800 
nm with 2.5% laser power from the two-photon laser pulsing at 80 fs 
at a repetition of 80 MHz. The laser light was separated from the 
fluorescence signal using an SP 760-nm dichroic filter. The fluores-
cence signal was directed through a 509 LP CFP/yellow fluorescent 
protein (YFP) filter; the signal was then split between two photomul-
tiplier detectors (H7422P-40; Hamamatsu),equipped with either a 
CFP 470/22 or YFP 542/27 bandwidth filter. FLIM data were ac-
quired with the SimFCS software developed at the Laboratory of 
Fluorescence Dynamics at the University of California, Irvine, with a 
dwell time of 25.61 µs/pixel and the pixel frame size set to 256 × 
256, and the electronic zoom used to enhance resolution produced 
an image size of 24.53 × 24.53 µm (pixel size of ∼100 nm). Fifty 
frames were collected per sample to limit exposure time to the laser 
to ∼1.5–2 min. For each experiment, a solution of 50 µM coumarin 6 
(Sigma-Aldrich) dissolved in 100% ethanol was imaged as a calibra-
tion control. Zen Black 2012 (Zeiss) was used to control the 
microscope and collect confocal images of the mCherry/mApple 
cellular markers acquired in parallel with FLIM data and images of 
fixed cells.
Data analysis. FLIM data were processed to map the fraction of 
FRET for each cell using the SimFCS software (Laboratory of Fluo-
rescence Dynamics, University of California, Irvine) as described 
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